Robert Bergstrand

1.6k total citations
41 papers, 1.3k citations indexed

About

Robert Bergstrand is a scholar working on Cardiology and Cardiovascular Medicine, Analytical Chemistry and Pharmacology. According to data from OpenAlex, Robert Bergstrand has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 9 papers in Analytical Chemistry and 6 papers in Pharmacology. Recurrent topics in Robert Bergstrand's work include Analytical Methods in Pharmaceuticals (9 papers), Cardiac electrophysiology and arrhythmias (7 papers) and Pharmacology and Obesity Treatment (5 papers). Robert Bergstrand is often cited by papers focused on Analytical Methods in Pharmaceuticals (9 papers), Cardiac electrophysiology and arrhythmias (7 papers) and Pharmacology and Obesity Treatment (5 papers). Robert Bergstrand collaborates with scholars based in Sweden, United States and Netherlands. Robert Bergstrand's co-authors include A Vedin, Lars Wilhelmsen, Claes Wilhelmsson, Göran Ulvenstam, Anders Åberg, Hans Wedel, Saga Johansson, Bertil Olofsson, Anders Sandberg and S. Johansson and has published in prestigious journals such as Gastroenterology, Diabetes and American Journal of Epidemiology.

In The Last Decade

Robert Bergstrand

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Bergstrand Sweden 21 795 224 129 122 114 41 1.3k
H. Wesseling Netherlands 24 1.0k 1.3× 176 0.8× 197 1.5× 177 1.5× 79 0.7× 132 2.0k
John A. Opsahl United States 17 457 0.6× 197 0.9× 63 0.5× 129 1.1× 85 0.7× 48 1.1k
L E Ramsay United Kingdom 17 676 0.9× 341 1.5× 143 1.1× 302 2.5× 29 0.3× 50 1.4k
Rebecca A. Boyd United States 21 1.4k 1.7× 265 1.2× 241 1.9× 92 0.8× 46 0.4× 34 2.4k
GT McInnes United Kingdom 14 801 1.0× 241 1.1× 71 0.6× 264 2.2× 39 0.3× 53 1.6k
M Pfeffer United States 16 325 0.4× 229 1.0× 42 0.3× 90 0.7× 44 0.4× 28 1.3k
Stephanie Läer Germany 28 909 1.1× 209 0.9× 216 1.7× 71 0.6× 94 0.8× 70 2.2k
C. Venkata S. Ram United States 22 1.0k 1.3× 298 1.3× 48 0.4× 346 2.8× 45 0.4× 119 1.8k
Jerry L. Bauman United States 24 1.1k 1.4× 90 0.4× 155 1.2× 53 0.4× 42 0.4× 108 2.1k
Lindon Wing Australia 19 499 0.6× 148 0.7× 128 1.0× 172 1.4× 19 0.2× 55 1.1k

Countries citing papers authored by Robert Bergstrand

Since Specialization
Citations

This map shows the geographic impact of Robert Bergstrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Bergstrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Bergstrand more than expected).

Fields of papers citing papers by Robert Bergstrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Bergstrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Bergstrand. The network helps show where Robert Bergstrand may publish in the future.

Co-authorship network of co-authors of Robert Bergstrand

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Bergstrand. A scholar is included among the top collaborators of Robert Bergstrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Bergstrand. Robert Bergstrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elmfeldt, Dag, et al.. (2015). General Aspects of Secondary Prevention after Myocardial Infarction. Advances in cardiology. 94–104.
2.
Darpö, Börje, H Vallin, Olle Almgren, et al.. (1995). Selective Ik Blocker Almokalant Exhibits Class Ill-Specific Effects on the Repolarization and Refractoriness of the Human Heart. Journal of Cardiovascular Pharmacology. 26(4). 530–540. 12 indexed citations
3.
Darpö, Börje, et al.. (1995). Tolerance and Effects of Almokalant, a New Selective Ik Blocking Agent, on Ventricular Repolarization and on Sino-Atrial and Atrioventricular Nodal Function in the Heart. Journal of Cardiovascular Pharmacology. 25(5). 681–690. 14 indexed citations
4.
Kennedy, Harold L., Maria M. Brooks, Allan H. Barker, et al.. (1994). Beta-blocker therapy in the cardiac arrhythmia suppression trial. The American Journal of Cardiology. 74(7). 674–680. 118 indexed citations
5.
6.
Wiesfeld, Ans C.P., Harry J.G.M. Crijns, Robert Bergstrand, et al.. (1993). Torsades de pointes with Almokalant, a new class III antiarrhythmic drug. American Heart Journal. 126(4). 1008–1011. 25 indexed citations
7.
Wiesfeld, Ans C.P., Harry J. Crijns, T Tobe, et al.. (1992). Electropharmacologic effects and pharmacokinetics of almokalant, a new class III antiarrhythmic, in patients with healed or healing myocardial infarcts and complex ventricular arrhythmias. The American Journal of Cardiology. 70(11). 990–996. 15 indexed citations
8.
Andersson, Tommy, Robert Bergstrand, C. Cederberg, et al.. (1991). Omeprazole treatment does not affect the metabolism of caffeine. Gastroenterology. 101(4). 943–947. 37 indexed citations
9.
Andersson, Tommy, Robert Bergstrand, & C. Cederberg. (1991). Influence of acid secretory status on absorption of omeprazole from enteric coated granules.. British Journal of Clinical Pharmacology. 31(3). 275–278. 24 indexed citations
10.
Lücker, P W, et al.. (1990). Pharmacokinetic and Pharmacodynamic Comparison of Metoprolol CR/ZOK Once Daily with Conventional Tablets Once Daily and in Divided Doses. The Journal of Clinical Pharmacology. 30(S2). S17–27. 39 indexed citations
11.
Lundborg, Per, et al.. (1990). Pharmacokinetic and Pharmacodynamic Evaluation of Metoprolol Controlled Release (CR/ZOK) 50 mg in Young Subjects. The Journal of Clinical Pharmacology. 30(S2). S28–32. 16 indexed citations
12.
Abrahamsson, Bertil, P W Lücker, Bertil Olofsson, et al.. (1990). The Relationship Between Metoprolol Plasma Concentration and Beta1‐Blockade in Healthy Subjects: A Study on Conventional Metoprolol and Metoprolol CR/ZOK Formulations. The Journal of Clinical Pharmacology. 30(S2). S46–54. 38 indexed citations
13.
Sandberg, Anders, et al.. (1990). Pharmacokinetic and Biopharmaceutic Aspects of Once Daily Treatment with Metoprolol CR/ZOK: A Review Article. The Journal of Clinical Pharmacology. 30(S2). S2–16. 42 indexed citations
14.
LINDÉN, T., Göran Bondjers, Germán Camejo, et al.. (1989). Affinity of LDL to a human arterial proteoglycan among male survivors of myocardial infarction. European Journal of Clinical Investigation. 19(1). 38–44. 42 indexed citations
15.
Siddoway, Lyle A., et al.. (1988). The development and testing of intravenous dosing regimens: Application to flecainide for the suppression of ventricular arrhythmias. Clinical Pharmacology & Therapeutics. 43(5). 499–508. 6 indexed citations
16.
Ulvenstam, Göran, Robert Bergstrand, Saga Johansson, et al.. (1984). Prognostic importance of cholesterol levels after myocardial infarction. Preventive Medicine. 13(4). 355–366. 29 indexed citations
17.
Johansson, S., et al.. (1984). Sex differences in cardioangiographic findings after myocardial infarction. European Heart Journal. 5(5). 374–381. 41 indexed citations
18.
Johansson, Saga, Robert Bergstrand, Göran Ulvenstam, et al.. (1984). SEX DIFFERENCES IN PREINFARCTION CHARACTERISTICS AND LONGTERM SURVIVAL AMONG PATIENTS WITH MYOCARDIAL INFARCTION. American Journal of Epidemiology. 119(4). 610–623. 85 indexed citations
19.
Bergstrand, Robert, A Vedin, Claes Wilhelmsson, & Lars Wilhelmsen. (1982). Incidence and prognosis of acute myocardial infarction among men below age 40 in Göteborg, Sweden. European Heart Journal. 3(2). 130–135. 19 indexed citations
20.
Björnheden, Tom, Olov Wiklund, Robert Bergstrand, & Göran Bondjers. (1980). Skin Cholesterol and DNA in Young Patients with Myocardial Infarction. Acta Medica Scandinavica. 207(1-6). 271–277. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Wesseling Breakdown of academic impact, for papers by John A. Opsahl Breakdown of academic impact, for papers by L E Ramsay Breakdown of academic impact, for papers by Rebecca A. Boyd Breakdown of academic impact, for papers by GT McInnes Breakdown of academic impact, for papers by M Pfeffer Breakdown of academic impact, for papers by Stephanie Läer Breakdown of academic impact, for papers by C. Venkata S. Ram Breakdown of academic impact, for papers by Jerry L. Bauman Breakdown of academic impact, for papers by Lindon Wing
Rankless by CCL
2026